solgar l-glutathione 250 mg Solgar Reduced L-Glutathione, 250 mg,

Findings are experimental and observational

Contraindications Contraindications for this combination are the individual contraindications of each compound: GHK-Cu should be avoided if you have: Wilson's disease or other copper metabolism disorders Known allergy to copper or copper peptides Semaglutide should be avoided if you have: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 Active or recent pancreatitis Pregnancy or breastfeeding Monitoring Recommendations For patients using GHK-Cu alongside semaglutide, we recommend: Standard semaglutide monitoring (metabolic panel, HbA1c, lipids at baseline and periodically) Copper and ceruloplasmin levels at baseline if there's any concern about copper metabolism Skin assessment at each follow-up to evaluate tissue response General nutritional assessment to ensure adequate micronutrient intake Monitoring and lab work Frequently Asked Questions Can GHK-Cu cause copper toxicity when used with semaglutide

K.PiaoM

It is an established research compound, but material here is provided for laboratory use only